{"disease":{"id":"psp","name":"psp"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04363684","title":"ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)","phase":"","overall_status":"RECRUITING","enrollment_count":2100,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06949865","title":"AI-Enhanced Optimization of Acute Levodopa Challenge Test","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT06647641","title":"The CurePSP Genetics Program","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04715399","title":"UPenn Observational Research Repository on Neurodegenerative Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT03030586","title":"ADDIA Proof-of-Performance Clinical Study","phase":"","overall_status":"COMPLETED","enrollment_count":821,"lead_sponsor_name":"Amoneta Diagnostics SAS","has_results":false},{"nct_id":"NCT07392411","title":"Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers","phase":"","overall_status":"RECRUITING","enrollment_count":720,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT07141719","title":"Collection of Digital Parameters From Parts of the Neurological Examination Using an Eye Tracker","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"University of Kiel","has_results":false},{"nct_id":"NCT07173803","title":"The Progressive Supranuclear Palsy Clinical Trial Platform","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":440,"lead_sponsor_name":"Adam Boxer","has_results":false},{"nct_id":"NCT07331805","title":"Conservative Management in Primary Spontaneous Pneumothorax: a Multicenter Randomized Non-inferiority Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":436,"lead_sponsor_name":"Corporacion Parc Tauli","has_results":false},{"nct_id":"NCT07498426","title":"A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04193527","title":"A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"GE Healthcare","has_results":true},{"nct_id":"NCT07264283","title":"The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":147,"lead_sponsor_name":"Adam Boxer","has_results":false},{"nct_id":"NCT07217665","title":"The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":146,"lead_sponsor_name":"Adam Boxer","has_results":false},{"nct_id":"NCT03391765","title":"An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":142,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT07316413","title":"Repetitive Transcranial Magnetic Stimulation in Frontotemporal Lobar Degeneration","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Università degli Studi di Brescia","has_results":false},{"nct_id":"NCT06122662","title":"AMX0035 and Progressive Supranuclear Palsy","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Amylyx Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT02839642","title":"Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT07240805","title":"Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"BioSensics","has_results":false},{"nct_id":"NCT07429019","title":"Intraoperative Bupivacaine Injection to Reduce Acute and Chronic Pain After TVT/TVT-O Surgery. Randomized Double-Blind Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Hadassah Medical Organization","has_results":false},{"nct_id":"NCT05956834","title":"A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04539041","title":"Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03330353","title":"Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy","phase":"","overall_status":"UNKNOWN","enrollment_count":56,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT07413731","title":"Neurophysiological Effects of Medication Tapering During Treatment With Spinal Cord Stimulation","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Brai²n","has_results":false},{"nct_id":"NCT06597071","title":"Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":40,"lead_sponsor_name":"NeuraLight","has_results":false},{"nct_id":"NCT05121012","title":"Synaptic Loss in Multiple System Atrophy","phase":"","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"University of Exeter","has_results":false},{"nct_id":"NCT06740591","title":"HD-tDCS for Pain Reduction in Post-Stroke Pain: a Randomized Crossover Trial","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Pusan National University Yangsan Hospital","has_results":false},{"nct_id":"NCT03545126","title":"Human CNS Tau Kinetics in Tauopathies","phase":"","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT07502612","title":"Evaluation of Medication Tapering on the Sensitivity of the Spinal Cord Using Closed-Loop Spinal Cord Stimulation (Pilot Study)","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Brai²n","has_results":false},{"nct_id":"NCT03413319","title":"Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT05206591","title":"Study to Demonstrate the Efficacy and Safety of Secukinumab up to 224 Weeks in Subjects With Active Peripheral Spondyloarthritis (pSpA).","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":30},"guidelines":[],"source":"Drug Landscape verified database"}